Immunovant, Inc.
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership672,774 shares
Latest Disclosed Value $ 16,711,707
Northern Trust Corp reports 18.83% increase in ownership of IMVT / Immunovant, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 672,774 shares of Immunovant, Inc. (US:IMVT) valued at $16,711,706 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 566,148 shares of Immunovant, Inc.. This represents a change in shares of 18.83% during the quarter. The current value of the position is $21,979,527 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IMMUNOVANT COM 45258J102 672,774 106,626 18.83 16,712 16.12 0.0005
2026-02-17 2025-12-31 13F IMMUNOVANT COM 45258J102 566,148 10,233 1.84 14,391 60.60 0.0004
2025-11-14 2025-09-30 13F IMMUNOVANT COM 45258J102 555,915 -19,468 -3.38 8,961 -2.66 0.0003
2025-08-13 2025-06-30 13F IMMUNOVANT COM 45258J102 575,383 38,761 7.22 9,206 0.39 0.0013
2025-05-13 2025-03-31 13F IMMUNOVANT COM 45258J102 536,622 9,255 1.75 9,171 -29.80 0.0014
2025-02-14 2024-12-31 13F IMMUNOVANT COM 45258J102 527,367 20,377 4.02 13,063 -9.63 0.0018
2024-11-13 2024-09-30 13F IMMUNOVANT COM 45258J102 506,990 43,269 9.33 14,454 18.07 0.0024
2024-08-14 2024-06-30 13F IMMUNOVANT COM 45258J102 463,721 -14,986 -3.13 12,242 -20.85 0.0021
2024-05-14 2024-03-31 13F IMMUNOVANT COM 45258J102 478,707 -15,987 -3.23 15,467 -25.79 0.0027
2024-02-13 2023-12-31 13F IMMUNOVANT COM 45258J102 494,694 15,326 3.20 20,841 13.25 0.0038
2023-11-13 2023-09-30 13F IMMUNOVANT COM 45258J102 479,368 -13,492 -2.74 18,403 96.83 0.0036
2023-08-11 2023-06-30 13F IMMUNOVANT COM 45258J102 492,860 81,813 19.90 9,350 46.65 0.0018
2023-05-15 2023-03-31 13F IMMUNOVANT COM 45258J102 411,047 -6,896 -1.65 6,375 -14.06 0.0013
2023-02-13 2022-12-31 13F IMMUNOVANT COM 45258J102 417,943 68,068 19.45 7,418 279.83 0.0016
2022-11-14 2022-09-30 13F IMMUNOVANT COM 45258J102 349,875 -7,366 -2.06 1,953 40.10 0.0004
2022-08-12 2022-06-30 13F IMMUNOVANT COM 45258J102 357,241 -11,245 -3.05 1,394 -31.36 0.0003
2022-05-13 2022-03-31 13F IMMUNOVANT COM 45258J102 368,486 -20,910 -5.37 2,031 -38.81 0.0004
2022-02-08 2021-12-31 13F IMMUNOVANT COM 45258J102 389,396 -1,649 -0.42 3,319 -2.35 0.0005
2021-11-15 2021-09-30 13F IMMUNOVANT COM 45258J102 391,045 -26,265 -6.29 3,399 -22.93 0.0006
2021-08-13 2021-06-30 13F IMMUNOVANT COM 45258J102 417,310 -32,341 -7.19 4,410 -38.86 0.0008
2021-05-12 2021-03-31 13F IMMUNOVANT COM 45258J102 449,651 -17,187 -3.68 7,213 -66.55 0.0013
2021-02-11 2020-12-31 13F IMMUNOVANT COM 45258J102 466,838 37,807 8.81 21,564 42.83 0.0042
2020-11-16 2020-09-30 13F IMMUNOVANT COM 45258J102 429,031 155,699 56.96 15,098 126.87 0.0033
2020-08-14 2020-06-30 13F IMMUNOVANT COM 45258J102 273,332 251,701 1,163.61 6,655 1,874.78 0.0016
2020-05-14 2020-03-31 13F IMMUNOVANT COM 45258J102 21,631 -1,943 -8.24 337 -9.89 0.0001
2020-02-14 2019-12-31 13F IMMUNOVANT COM 45258J102 23,574 23,574 374 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.